Study wrapper · #931
Multi-omic profiling reveals Retatrutide alleviates adipose tissue fibrosis via metabolic reprogramming and tissue repair.
Li Q, Cheng W, Zhang J, et al. Diabetology & metabolic syndrome. 2026.
DOI: 10.1186/s13098-026-02116-0PubMed: 41964043
Editor's note
This is a single mechanistic study in a high-fat-diet mouse model using multi-omic profiling, so results are preliminary and not human data. Retatrutide was associated with suppressed lipogenesis, enhanced fatty acid oxidation, and reduced fibrotic and inflammatory signaling in white adipose tissue. The authors frame tissue-quality restoration as a hypothesis for further study.
Plain-language abstract
In a mouse model of diet-induced obesity, retatrutide reduced body weight and was associated with reduced fat-tissue inflammation and fibrosis alongside improved fat metabolism.
Related coverage
Supported
Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.
BMJ (Clinical research ed.)n=——2026
Weak / none
Effects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats.
Behavioural brain researchn=——2026
Supported
Effect of Retatrutide, a Novel Triple Receptor Agonist, on Blood Pressure and Lipid Levels: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
High blood pressure & cardiovascular preventionn=——2026